T
T. van Dalen
Researcher at Utrecht University
Publications - 40
Citations - 917
T. van Dalen is an academic researcher from Utrecht University. The author has contributed to research in topics: Breast cancer & Cancer registry. The author has an hindex of 13, co-authored 34 publications receiving 743 citations.
Papers
More filters
Journal ArticleDOI
Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial.
Nicky H. G. M. Peters,S. van Esser,M. A. A. J. van den Bosch,Remmert K Storm,Peter W. Plaisier,T. van Dalen,Suzanne C. E. Diepstraten,Teun Weits,Pieter J. Westenend,Gerard Stapper,M.A. Fernandez-Gallardo,I. H. M. Borel Rinkes,R. van Hillegersberg,W.P.Th.M. Mali,P. H. M. Peeters +14 more
TL;DR: Addition of MRI to routine clinical care in patients with nonpalpable breast cancer was paradoxically associated with an increased re-excision rate, and breast MRI should not be used routinely for preoperative work-up of patients withNonpalpables breast cancer.
Journal ArticleDOI
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)
L.M. van Roozendaal,M. Vane,T. van Dalen,J.A. van der Hage,Luc J. A. Strobbe,Liesbeth J. Boersma,Sabine C. Linn,Marc B. I. Lobbes,Philip Poortmans,Vivianne C. G. Tjan-Heijnen,K.K. Van de Vijver,J. de Vries,A.H. Westenberg,Alphons G.H. Kessels,J.H.W. de Wilt,Marjolein L. Smidt +15 more
TL;DR: If the sentinel lymph node biopsy can be safely omitted in clinically node negative breast cancer patients undergoing breast conserving therapy, this study will cost-effectively lead to a decreased axillary morbidity rate and thereby improved quality of life with non-inferior regional control, distant-disease free survival and overall survival.
Journal ArticleDOI
Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study
Paul D. Gobardhan,Sjoerd G. Elias,E. V. E. Madsen,V. Bongers,H. M. Ruitenberg,C. I. Perre,T. van Dalen +6 more
TL;DR: Micrometastatic lymph node involvement in itself should not be an indication for adjuvant chemotherapy in breast cancer patients, and no statistically significant differences were observed in overall or disease-free survival between (p)N(0) and (p(1micro).
Journal ArticleDOI
Local recurrence after surgery for primary extra‐abdominal desmoid‐type fibromatosis
D L M van Broekhoven,Cees Verhoef,S. G. Elias,Arjen J. Witkamp,J. Van Gorp,B. Van Geel,H. K. Wijrdeman,T. van Dalen +7 more
TL;DR: Although there is a trend towards conservative treatment, surgery remains the standard treatment for extra‐abdominal desmoid tumours.
Journal ArticleDOI
Intraoperative ultrasound guidance for excision of non-palpable invasive breast cancer: a hospital-based series and an overview of the literature
Maarten W. Barentsz,T. van Dalen,Paul D. Gobardhan,V. Bongers,C. I. Perre,Ruud M. Pijnappel,M. A. A. J. van den Bosch,Helena M. Verkooijen +7 more
TL;DR: For localization of non-palpable breast cancer, IOUS is a reliable alternative to GWL, as it achieves similar results in terms of complete tumor removal, re-excision rate and excised volume.